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ABSTRACT 
Background: Obesity in childhood predisposes individuals to cardiovascular disease and 
increased risk of premature all-cause mortality. The aim of this study was to determine 
differences in LV morphology and function in obese and normal-weight adolescents. 
Furthermore, relationships between LV outcomes, cardiorespiratory fitness (CRF) and 
adiposity were explored. 
Methods: LV morphology was assessed using magnetic resonance imaging (MRI) in 20 
adolescents (11 normal-weight [BMI equivalent to 18kg/m
2–25 kg/m2] and 9 obese [BMI 
equivalent to ≥30 kg/m2]); 13.3±1.1 years, 45% female, Tanner puberty stage 3 [2–4]) using 
magnetic resonance imaging (MRI). Global longitudinal strain (GLS), strain rate (SR) and 
traditional echocardiographic indices were used to assess LV function. CRF (peak oxygen 
consumption), percent body fat (dual-energy x-ray absorptiometry), abdominal adipose tissue 
(MRI), and blood biochemistry markers were also evaluated.  
Results: Adolescents with obesity showed significantly poorer LV function compared to 
normal-weight adolescents (P<0.05) indicated by higher GLS (+6.29 %) and SR in systole 
(+0.17 s
-1
), and lower SR in early diastole (-0.61 s
-1
), and tissue Doppler velocities (S’ -2.7 
cm/s; e’ -2.3 cm/s; A’ -1.1 cm/s). There were no group differences in LV morphology when 
indexed to fat free mass (P>0.05). Moderate to strong associations between myocardial 
contractility and relaxation, adiposity, arterial blood pressure and cardiorespiratory fitness 
were noted (r=0.49–0.71, P<0.05).   
Conclusion: Obesity in adolescence is associated with altered LV systolic and diastolic 
function. The notable relationship between LV function, CRF and adiposity highlights the 
potential utility of multidisciplinary lifestyle interventions to treat diminished LV function in 
this population. 
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INTRODUCTION 
 Paediatric obesity, which affects approximately 17% of children and adolescents 
worldwide [1], is likely to persist into young adulthood and adversely impacts multiple 
cardiovascular risk factors [2]. In fact, adiposity in paediatric life is a consistent predictor of 
increased left ventricular mass (LVM) in young adults [3]. Left ventricular hypertrophy 
(LVH), which manifests as increased LVM, has been established as a strong predictor of heart 
failure events and may increase the risk of sudden cardiac death in adults [4]. Obese 
adolescents have significantly greater absolute and relative LVM compared to normal-weight 
adolescents, when assessed through magnetic resonance imaging (MRI) [5,6] and 
echocardiography [7,8]. When combined with subclinical alterations in left ventricular (LV) 
systolic and diastolic function [9,10], including lower strain, and strain rates (SR) compared 
to normal-weight adolescents [11-13], obese adolescents may be at an increased risk for 
cardiovascular disease events.  
To comprehensively assess the cardiovascular risk associated with adolescent obesity, 
MRI-quantified LVM should be normalised to FFM to accurately account for differences in 
body composition [10] and increase sensitivity for detection of LVH [14]. Furthermore, these 
data should be accompanied by assessments of global longitudinal strain (GLS) and SR, 
which provide diagnostic information on both ventricular deformation and deformation rate 
thereby offering an accurate non-invasive assessment of cardiac contractility and relaxation 
[15]. Lastly, the mechanisms that underlie altered left ventricular function and structure in 
paediatric obesity are uncertain. There is minimal evidence attributing diminished LV 
function and altered LV structure to either obesity per se [9,10], associated co-morbidities 
including insulin resistance [16] or cardiorespiratory deconditioning [17]. Together, these 
analyses are yet to be conducted in a population of adolescents with obesity.  
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 Therefore, the aims of this investigation were to compare 1) cardiac MRI-derived 
outcomes of LV morphology, and 2) speckle tracking echocardiography-derived GLS and SR 
in systole, early and late diastole, between obese and normal-weight adolescents. We also 
wanted to determine the associations between LV measures, adiposity and metabolic co-
morbidities, and cardiorespiratory fitness (CRF). 
SUBJECTS AND METHODS 
Twenty adolescents aged 12–16 years (9 obese, BMI ≥ percentile curves that pass 
through 30 kg/m
2
 at age 18 and 11 normal-weight, BMI percentile curves that pass through 18 
kg/m
2 – 25 kg/m2 at age 18) [18] were recruited as part of a multi-centre randomised 
controlled trial at The University of Queensland, Brisbane, Australia (Clinicaltrials.gov 
NCT01991106). The study protocol conforms to the ethical guidelines of the 1975 
Declaration of Helsinki as reflected in a priori approval by The University of Queensland 
Human Research Ethics Committee (reference number 2013000539) and The Mater Hospital 
Human Research Ethics Committee (reference number HREC/13/MHS/119/AM01). 
Participants’ parents or legal guardians approved consent, and participants provided written 
assent prior to participation. Details of inclusion and exclusion criteria, recruitment methods 
and physiological assessments have been previously described [19]. In brief, height and 
weight were measured for calculation of body mass index (BMI) and body surface area 
(BSA), and participants self-reported their stage of puberty using the Tanner scale [20]. 
Additional assessments included blood sampling (first visit), a cardiac and abdominal MRI 
scan and echocardiographic study (second visit), and a maximal exercise test and body 
composition scan (third visit).  The assessments were completed over a two-week period 
(maximum) and were separated by at least 24 hours. 
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Cardiac MRI 
 LV morphology was quantified using a 1.5T cardiac MRI unit (Siemens Symphony 
Sonata, Siemens, Erlangen, Germany). Standard scout images were used to locate the 
orthogonal planes of the heart. A TrueFISP sequence was used to acquire images in a supine 
position with a posterior phased array spine coil and an anterior phased array body surface 
coil. For all sequences, the breath-hold times were between 5–15 seconds. End-expiratory 
ECG triggered short axis plane images (16 slices, repetition time=41.02ms, echo 
time=1.25ms, flip angle=70 °, field of view=350mm, slice thickness=8mm, bandwidth=930) 
were then acquired throughout the ventricles covering the base (atrioventricular valve plane) 
to the apex. Cine images of the four-chamber view were also acquired (repetition 
time=39.9ms, echo time=1.22ms, flip angle=70 °, field of view=340mm, slice 
thickness=10mm, bandwidth=930). Data were analysed using specialised commercially 
available software for assessment of LV morphology (Syngo.via, vb10b, Siemens, Erlangen, 
Germany) and epicardial adipose tissue (EAT) volume (SliceOmatic Version 5.0, 
Tomovision, Magog, Canada) by trained observers. The laboratory-specific coefficient of 
variation for repeated cardiac MRI LV morphology outcomes is 1.1– 2.5% (interclass 
correlation=0.95–0.97).  
Short axis cine loops were used to determine end systole, defined as the frame with 
the smallest ventricular cavity. Contours were drawn around endocardial and epicardial LV 
borders, including the septum but excluding the papillary muscles. The papillary muscles 
were added to LV end-systolic volume (LVESV) and LV end-diastolic volume (LVEDV) and 
from this, stroke volume (SV) and ejection fraction (EF) were calculated. LVM was 
determined by summing the LVEDV within the epi- and the endocardial borders as 
previously described [21], and multiplying the volume by the specific density of the 
myocardium (1.05g/cc). The four-chamber cine loops were used to determine LV internal 
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diameter at systole and diastole (LVIDs and LVIDd), and interventricular septum thickness 
(IVST) during end-diastole. LVIDs and LVIDd were measured 1–2 slices (8–16mm) below 
the valvular leaflets, while IVST was measured approximately 24–36mm below the valvular 
leaflets [22]. EAT volume was also quantified at end-diastole using short-axis cine loops 
covering the entire left and right ventricle. EAT cross-sectional area was multiplied by slice 
thickness to obtain EAT volume, and slice volumes were summed to obtain total EAT 
volume. Measures of LV structure and EAT volume are presented as absolute values and 
were also linearly scaled to FFM to create an ‘index’ which reduces the confounding effects 
of differing body size [23,24].  
Echocardiography 
A full resting echocardiographic assessment was conducted by an experienced 
sonographer using a Vivid 7 or E9 ultrasound machine (GE Vingmed Ultrasound AS, Horten, 
Norway) using a phased array transducer (GE M3S, 1.5–4 MHz). Participants lay in the left 
lateral decubitus position and three cine loops from the parasternal and the three standard 
apical planes (four chamber, two chamber and long axis) were recorded in grey-scale 
harmonic mode and colour tissue Doppler imaging (apical views). To optimize image quality, 
the sector depth and width were adjusted for each participant, resulting in a mean B-mode 
frame rate of at least 55 frames/second. To determine the timing of cardiac events, tissue 
Doppler velocity curves (sample volume at the basal septum) were conducted immediately 
before acquisition of short-axis images, which minimised changes in heart rate. Aortic valve 
closure (AVC) was defined at the end of the negative spike after ejection [25]. The images 
were digitally stored on a hard drive for offline analysis. EchoPAC (Version 112, GE Medical 
Systems, Milwaukee, WI, USA) was used for echocardiographic analysis by a trained 
investigator and a cardiologist.  
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Standard Doppler and Tissue Doppler  
LV standard Doppler echocardiographic indices were measured from parasternal and 
apical views. Peak early (E) and late (A) mitral inflow velocities were measured using pulsed-
wave Doppler imaging at the leaflet tips. Peak mitral annular systolic (S’), early (e’) and late 
(A’) diastolic tissue velocities were measured through pulsed-wave Doppler mode and are 
presented as mean values of the four sites (septal, lateral, anterior and inferior). The ratio 
between E and A, and, E and e’ was calculated to determine LV filling and LV filling 
pressure, respectively.  
Myocardial Speckle Tracking 
GLS and SR measurements were obtained from three wall segments: basal, midwall, 
and apical using three apical views (4 chamber, 2 chamber and apical long axis). In all 
orientations, frame rates were maximised and ranged from 50–120 frames/second. All images 
were optimised using gain, compression, and dynamic range to enhance myocardial 
definition. For analysis of GLS, one cardiac cycle from the apical long-axis images with a 
well-defined late-systolic endocardial border was selected for analysis. Regions of interest of 
the left ventricle were adjusted to include most of the myocardium, but not the pericardium. 
The endocardial borders at end-systole were manually traced and subsequently tracked by the 
software. In cases where the software or the observer identified poor tracking quality, the 
region of interest was re-adjusted until acceptable tracking quality was obtained. Segments 
that continued to display poor tracking quality were discarded. Default spatial and temporal 
smoothing was applied. Myocardial deformation was determined from continuous frame-by-
frame tracking of the ‘kernels’ and GLS and SR were calculated from the displacement and 
rate of displacement. Mid-myocardial values for all available planes were averaged to provide 
GLS, and SR values in systole, early diastole and late diastole.  
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Cardiorespiratory fitness 
Participants completed a maximal exercise treadmill test with continuous breath-by-
breath respiratory gas analysis (Metamax 3B, Cortex Biophysik GmbH, Leipzig, Germany) 
and a facemask system (Hans Rudolph, KS, USA). Calibration procedures have been outlined 
elsewhere [19]. After three minutes of rest, participants completed a four-minute warm up at 
4km/h while they were familiarized with treadmill walking. Thereafter, treadmill inclination 
was increased by 2% each minute to a maximum gradient of 12–16%. Following this, 
treadmill speed was increased by 1km/h each minute until volitional exhaustion. Heart rate 
was measured continuously during the test by radio telemetry (Polar, Polar Electro, Kempele, 
Finland). Peak oxygen uptake (VO2peak) was calculated as the average of the two highest 30-
second values attained.   
Abdominal adipose tissue and whole body composition 
MRI images were obtained using a 1.5T MRI unit (Siemens Symphony Sonata) as 
previously detailed [19]. In summary, 14x8mm axial slices centred over the umbilicus were 
acquired during breath hold. MRI scans were anonymised and analysed by a single 
investigator using SliceOmatic (Version 5.0, Tomovision, Magog, Canada). The average 
subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) cross-sectional area 
(CSA), and total SAT and VAT volumes were calculated. Average SAT and VAT CSA, and 
total SAT and VAT volumes were summed to quantify total abdominal adipose tissue 
(TAAT) CSA and volume. Intra-observer SAT and VAT analysis coefficient of variation was 
0.7% and 3.6%, respectively.  
Total body fat percentage, total fat mass and total fat free mass was determined using 
dual-energy x-ray absorptiometry (Discovery DXA System, Hologic QDR Series, 
Massachusetts, USA).  
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Biochemical analyses  
Detailed serum and plasma collection procedures have been outlined elsewhere [19]. 
Samples were analysed for fasting lipids and triglycerides, fasting glucose and HbA1c (Rx 
Daytona Plus, Randox Laboratories, Crumblin, County Amtrim, UK), and C peptide 
(electrochemiluminescence immunoassay [ECLIA], Cobas e411 immunoassay analyzer, 
Roche Diagnostics, Indianapolis, IN, USA). The Homeostatic Model Assessment was used to 
calculated insulin resistance (HOMA-IR), beta cell function (HOMA-B) and insulin 
sensitivity (HOMA-S) via the HOMA2 calculator (Version 2.2.3, University of Oxford, 
Oxford, United Kingdom) [26]. Basal disposition index (DI) was calculated as         
      
       
 to determine beta cell function at steady state allowing comparison between varying 
degrees of IR. The coefficients of variation were as follows: total cholesterol (1.0%), high-
density lipoprotein (1.0%), triglycerides (1.4%), fasting glucose (0.6%), C peptide (0.8%) and 
HbA1c (2.7%). 
Statistical analysis 
 Data are expressed as mean ± SD if continuous and normally distributed, or median 
(IQR) and percentages if categorical or non-normally distributed. Normality of data was 
assessed through visual examination of histograms and quantified using the Shapiro-Wilk 
test. A non-parametric test was used if the assumption of normality continued to be violated 
following data transformation. Independent t-tests or Mann-Whitney U tests, and 2 tests were 
used compare outcomes between normal-weight and obese adolescents. Hedges’ g effect sizes 
were calculated to further quantify between-group differences and were interpreted as 
follows: small effect (0.20), small-to-medium effect (0.20–0.50), medium-to-large effect 
(0.50 – 0.80) and large-to-very large effect (0.80–1.30) [27]. Effect sizes for non-normally 
distributed outcomes were calculated using the following equation:   
           
  
 and 
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interpreted using the aforementioned thresholds. Univariate linear regression modelling was 
to determine the association between LV function and structure, adipose tissue, insulin 
resistance and CRF outcomes in all adolescents. The strength of the r value was interpreted as 
weak (r≤0.1), moderate (r=0.3–0.5) or strong (r>0.5) [28]. SPSS Statistics (Version 24.0, 
IBM, Armonk, NY, USA) was used to perform the statistical analyses. All statistical tests 
with P value < 0.05 were considered significant.  
RESULTS 
Comparison of obese and normal-weight adolescents  
Table 1 illustrates clinical, CRF, body composition and blood biochemistry of obese 
(n=9) and normal-weight adolescents (n=11). There were no between-group differences for 
age, sex, and Tanner stages of puberty. As expected, obese adolescents exhibited key 
characteristics of obesity including increased weight, BMI, BSA, percent body fat and fat 
mass compared to normal-weight adolescents (P<0.001 between groups for all outcomes). 
Greater abdominal SAT, VAT and TAAT volume was also noted in obese versus normal-
weight adolescents (P<0.001 for all outcomes). Increased cardiac adiposity was noted among 
obese adolescents as indicated by greater absolute and indexed EAT volumes around the left 
and right ventricle compared to normal-weight adolescents (P≤0.001). Obese adolescents had 
significantly lower CRF than normal-weight adolescents, even when VO2peak was normalised 
to fat free mass (FFM) (P<0.001). Adolescent obesity was also associated with greater insulin 
resistance (HOMA IR, P=0.003).  
There was no difference in FFM-indexed LV structure between obese and normal-
weight adolescents (Table 2). However, the two groups exhibited contrasting LV function 
(Table 3). Obese adolescents had significantly higher GLS (P<0.001) and systolic SR 
(P=0.037), accompanied by reduced early diastolic SR (P=0.001), S’ (P=0.003), e’ (P=0.045), 
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A’ (P=0.041), and A (P=0.022) with medium to very large group differences noted (ES=0.5–
1.9).  
Associations of LV function and structure 
Table 4 illustrates the associations between LV function and structure, and markers of 
adiposity, cardiometabolic health and CRF.  GLS showed moderate to strong associations 
with total body fat percent (r=0.54, P=0.015), abdominal adipose tissue (r=0.67–0.71, 
P≤0.001) and arterial blood pressure (r=0.60-0.68, P≤0.005). Systolic strain rate was 
moderately associated with abdominal adipose tissue (r=0.49-0.50, P≤0.030) and arterial 
blood pressure (r=0.66-0.67, P≤0.002) while strain rate in early diastole was strongly 
associated with total body fat percent (r=0.64, P=0.002), abdominal adipose tissue (r=0.64-
0.72, P≤0.002). Both GLS and strain rate in early diastole were strongly associated with 
VO2peak (r=0.50, P=0.026 and r=0.58, P=0.008, respectively).  
DISCUSSION 
To the best of our knowledge, this is the first study to investigate FFM-indexed MRI-
quantified LV morphology concurrent with global longitudinal strain and strain rate among 
adolescents with obesity. Our findings illustrate that while paediatric obesity results in 
impaired global longitudinal strain and strain rate, there are no differences in MRI-derived, 
FFM-indexed LV morphology compared to normal-weight adolescents. These findings are 
consistent with pathological adult models including the early disease states of hypertension 
[29], ischaemia [30] and Type 2 Diabetes Mellitus (T2DM) [31]. Additionally, we found that 
reduced myocardial contractility and relaxation were strongly associated with total body and 
abdominal adiposity and insulin resistance while enhanced contractility and relaxation had a 
strong relationship with CRF.  
While our finding that obese adolescents have diminished LV function compared to 
normal-weight counterparts is consistent with earlier work, the observation that obese 
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adolescents have normal MRI-quantified LV morphology has not been reported. Previously, 
two studies found no significant differences in echocardiographic-derived absolute LVM [32] 
or indexed LVM (g/height) [32,33] between obese and normal-weight children. However, 
allometric indexation of LVM (height
1.85
 in males and height
1.72
 in females) did elicit a 
significant difference [32]. Several echocardiographic studies suggest that obese children 
have increased LVM compared to normal-weight children, however these findings are likely 
due to suboptimal indexation techniques [7-9,12,16]. Furthermore, although 
echocardiography is more commonly utilised for cardiac assessment, MRI provides superior 
accuracy when assessing cardiac volumes and masses [34]. Nevertheless, two MRI studies 
reported significantly greater absolute and height-adjusted LVM in obese versus normal-
weight adolescents [5,6] which is in direct contrast to our findings and likely due to different 
indexation techniques. The method of indexation and imaging methodology used is critical in 
determining the influence of adiposity on LV morphology and should be considered. 
We normalised LVM to dual-energy x-ray absorptiometry (DXA)-derived FFM to 
accurately compare our study populations in accordance with current recommendations 
[10,23] as at least 75 % of LVM variance is explained by FFM in children [24]. The majority 
of previous comparisons between normal-weight and obese paediatric populations indexed 
cardiac morphology outcomes to height although there were no significant different between 
groups, which may have misconstrued findings [7-9,12,16]. Additional error may be 
introduced when comparing populations with a wide age distribution  as FFM increases 
variably between males and females during puberty [35]. While we acknowledge that DXA-
derived FFM may be difficult to obtain, LVM indexed to BSA
1.5 
in the absence of FFM data 
may be more appropriate [23] and caution should be applied during data interpretation.  
 Our study found that obese adolescents had altered myocardial contractility 
characterised by reduced GLS and SR in systole in comparison to normal-weight adolescents. 
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These findings are consistent with previous comparisons of obese and normal-weight 
adolescents using both 2D-STE and tissue Doppler imaging-derived GLS and SR [8,9,11-
13,36] as well as 3D-wall motion tracking echocardiography [33]. However, when assessed 
using cardiac MRI, obese adolescents showed similar systolic SR to normal-weight 
counterparts [6]. This discrepancy is likely due to the significantly lower temporal resolution 
and therefore sensitivity of cardiac MRI compared to echocardiography to identify functional 
differences [37]. Importantly, although strain is affected by LV cavity size, GLS is expected 
to reduce as the ventricle becomes smaller [38]. Obese adolescents in the present study 
exhibited significantly reduced GLS alongside greater absolute LV cavity size (LVEDV) 
compared to their normal-weight counterparts. Therefore, the noted reduction in GLS among 
obese adolescents is not thought to be a consequence of differing absolute LVEDV between 
the study populations. The finding that obese adolescents have reduced systolic function is 
further supported by impaired S’ in obese adolescents compared to normal-weight controls 
reported in this study and previous work [8,11,13,33]. We also report altered diastolic 
function via reduced SR in early diastole and significantly lower e’, in obese versus normal-
weight adolescents, which is consistent with echocardiographic [11,12,32] and cardiac MRI 
findings [6]. Current evidence suggests that SR in late diastole appears intact among 
adolescents with obesity [6,12]. Together, it appears that paediatric obesity is associated with 
altered systolic function and a certain degree of diastolic impairment compared to the non-
obese state. Our findings closely resemble the early disease states of intrinsic (hypertension 
[29] and ischaemia [30]) and extrinsic (T2DM [31]) cardiomyopathies. Patients with early 
diabetic cardiomyopathy show significantly reduced myocardial contractility [39] that is 
further amplified in co-existence with LVH [39]. Indeed, reduced longitudinal function in the 
absence of ischaemia or LVH may occur with preserved EF and SV due to compensatory 
increased radial contractility [40]. While we did not assess radial contractility per se, this is 
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likely preserved in paediatric obesity, thereby permitting normal EF [9,36]. Obesity-related 
comorbidities, including insulin resistance, lead to maladaptation in fatty acid metabolism, 
glucose uptake, protein synthesis, cardiac collagen content and mitochondrial function 
[10,16,41], which could deleteriously impact myocyte function and compliance [16]. Our 
findings were in agreement with these mechanistic underpinnings whereby obese adolescents 
exhibited greater insulin resistance and reduced basal DI, increased quantities of epicardial 
adipose tissue, and sub-optimal LV function.  
Among our study population, myocardial contractility and relaxation was significantly 
associated with adiposity, insulin resistance, arterial blood pressure and CRF. Adolescents 
with increased total body and abdominal adiposity, and insulin resistance exhibited reduced 
GLS and SR in systole and early diastole. On the contrary, adolescents with greater relative 
CRF had enhanced GLS and SR in systole. Myocardial deformation/rate, BMI and duration of 
obesity were previously found to be significantly associated (r=0.19–0.60) in two studies of 
obese children [33,42]. The deleterious effect of adiposity on LV function is further illustrated 
through weight-loss studies in morbidly obese adolescents. In these individuals, bariatric 
surgery-induced weight loss [43] or a low carbohydrate-diet induced weight loss [44] 
significantly improved LV diastolic function. Although significant weight loss (8–34%) in 
obese adolescents [43,44] may be effective for improving diastolic function, achieving and 
maintaining weight loss without regular exercise is often difficult [45]. Even in the absence of 
weight loss, exercise may elicit improvements in LV function [46] by increasing cardiac 
compliance and the contribution of early filling flow to total diastolic filling. Exercise can 
increase the elastic recoil generated during systole, causing a more rapid untwist during the 
isovolumic relaxation period [47]. The increased untwisting and active myocardial relaxation 
generates active suction of the blood from the atria [48] resulting in a rapid decrease in LV 
pressure and promotes early LV filling [49]. In fact, the untwisting mechanics appear to 
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contribute most to early rather than late diastolic LV filling [50]. Given the associations 
between adiposity, CRF and LV function, our group is currently investigating the effects of a 
multi-disciplinary lifestyle approach (exercise training combined with a nutrition 
intervention) on cardiac function in children and adolescents with obesity. We hypothesise 
that this intervention will maximise the beneficial effects on cardiac function by stimulating a 
decrease in adiposity and concomitant increases in CRF [19].  
Limitations of the present investigation include the cross-sectional study design and a 
small sample size. We were unable to conduct multivariate linear regression analyses due to 
the reduced number of observations. This was a sub-study of a larger multi-centre randomised 
controlled trial [19] and cardiac MRI investigations were limited to one centre. Furthermore, 
this outcome measure was confined to participants older than 12 years due to the difficulty of 
consecutive breath-holds required for the MRI protocol. Lastly, the cardiac MRI protocol 
used did not permit quantification of extracellular volume and therefore the presence of 
cardiac fibrosis was not assessed. We recommend that future investigations incorporate 
fibrosis assessment to further understand the ramifications of obesity in adolescence.  
In conclusion, our study demonstrated that although FFM-indexed LV structure is similar 
between obese and normal-weight adolescents, obese adolescents exhibit subclinical 
reductions in myocardial indices of contractility and relaxation. The strong association 
between LV function, fitness and adiposity advocates for lifestyle interventions to ameliorate 
reduced cardiac function in paediatric obesity.  
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Table 1. Comparison of clinical, cardiorespiratory fitness, body composition and blood 
biochemistry characteristics in obese and normal-weight adolescents.  
 
Obese (n = 9) 
Normal-weight  
(n = 11) 
P value ES 
Age 13.1 ± 1.0 13.5 ± 1.2 0.431 
 
Sex (F, %)  67 27 0.078 
 
Tanner Puberty Stage (1 – 4)  3 (2 – 4) 3 (2 – 4) 0.953 
 
Height (cm) 165.5 ± 10.2 164.3 ± 8.3 0.777 0.13 
Weight (kg) 86.8 ± 11.9 50.1 ± 8.7 <0.001 3.58 
Body mass index (kg/m
2
) 31.7 ± 3.5 18.5 ± 2.3 <0.001 4.56 
Body mass index Z-score 2.19 ± 0.24 -0.23 ± 0.67 <0.001 4.61 
Body surface area 2.0 ± 0.2 1.5 ± 0.2 <0.001 2.50 
Systolic BP (mmHg) 117 ± 7 107 ± 7 0.009 1.43 
Diastolic BP (mmHg) 67 ± 4 60 ± 5 0.005 1.53 
Resting HR (beats/min) 76 ± 13 77 ± 9 0.931 0.09 
Peak HR (beats/min) 196 ± 9 198 ± 7 0.717 0.25 
VO2peak (L/min) 2.67 ± 0.66 2.67 ± 0.58 0.995 0.00 
VO2peak (mL/kg/min) 30.6 ± 5.0 53.5 ± 7.5 <0.001 3.52 
VO2peak (mL/kg
FFM
/min) 64.3 ± 6.1 78.8 ± 7.5 <0.001 2.10 
Total body fat (%)  47.9 ± 5.0 23.0 ± 6.9 <0.001 4.06 
Total fat mass (kg) 39.0 ± 5.5 10.8 ± 4.6 <0.001 0.84 
Total fat free mass (kg) 41.1 ± 7.4 33.9 ± 6.0 0.027 1.08 
MRI TAAT CSA (cm
2
) 555.5 (485.0 –617.7) 77.9 (64.6 – 107.1) <0.001 0.84 
MRI TAAT volume (cm
3
) 6299.2 (6114.9 – 
6918.5) 
873.2 (683.7 – 
1199.6) 
<0.001 0.84 
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MRI VAT CSA (cm
2
) 63.4 ± 15.2 15.1 ± 5.3 <0.001 4.44 
MRI VAT volume (cm
3
) 710.6 ± 170.1 169.4 ± 59.5 <0.001 4.44 
MRI SAT CSA (cm
2
) 505.4 (419.9 – 
539.5) 
63.1 (49.5 – 88.6) <0.001 0.84 
MRI SAT volume (cm
3
) 5790.0 (5357.5 – 
6042.1) 
707.0 (554.7 – 
991.9) 
<0.001 0.84 
EAT volume (cm
3
) 34.8 ± 11.8 16.0 ± 7.1 0.001 1.98 
EATi (cm
3
/kgFFM) 0.85 ± 0.27 0.47 ± 0.18 <0.001 1.69 
Cholesterol (mmol/L) 4.05 ± 1.38 4.12 ± 1.02 0.893 0.06 
HDL (mmol/L) 1.06 ± 0.17 1.60 ± 0.37 0.002 1.74 
LDL (mmol/L) 2.35 ± 0.99 2.19 ± 0.72 0.695 0.19 
Triglycerides (mmol/L) 1.38 ± 0.82 0.71 ± 0.27 0.074 1.23 
Fasting glucose (mmol/L) 5.20 ± 0.46 5.23 ± 0.28 0.829 0.08 
C peptide (nmol/L) 0.99 ± 0.23 0.55 ± 0.13 <0.001 2.52 
HbA1c (%) 5.4 ± 0.33 5.3 ± 0.22 0.353 0.39 
HOMA-IR 2.2 ± 0.6 1.2 ± 0.3 0.003 2.29 
HOMA-B 153.4 ± 43.0 100.4 ± 22.4 0.003 1.67 
HOMA-S 48.8 ± 14.2 85.6 ± 23.5 0.002 1.79 
Basal DI 71.5 ± 13.8 82.4 ± 11.6 0.091 0.87 
 
ES, effect size; F, female; BP, blood pressure; HR, heart rate; VO2peak, peak oxygen uptake; 
MRI; magnetic resonance imaging; TAAT; total abdominal adipose tissue; CSA; cross-
sectional area; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; EAT, 
epicardial adipose tissue; EATi, epicardial adipose tissue index; HDL, high-density 
lipoprotein; LDL, low density lipoprotein; HbA1c, glycated haemoglobin; HOMA-IR, 
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HOMA of insulin resistance; HOMA-B, HOMA of beta cell function; HOMA-S, HOMA of 
insulin sensitivity; DI, disposition index 
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Table 2. Cardiac MRI-derived left ventricular structure outcomes for obese and normal-
weight adolescents 
 
Obese (n = 9) 
Normal-weight  
(n = 11) 
P value ES 
LVM (g) 105.5 (89.8 – 125.2) 90.3 (85.5 – 94.8) 0.112 0.37 
LVMi (g/kgFFM) 2.7 (2.4 – 2.8) 2.7 (2.6 – 3.1) 0.497 0.16 
LVEDV (mL) 175.2 ± 36.8 139.2 ± 24.6 0.018 1.18 
LVEDVi (mL/kgFFM) 4.3 ± 0.4 4.1 ± 0.3 0.374 0.57 
LVESV (mL) 68.2 ± 11.0 52.3 ± 10.6 0.004 1.48 
LVESVi (mL/kgFFM) 1.7 ± 0.2 1.6 ± 0.3 0.291 0.38 
Ejection fraction (%) 60.3 ± 5.8 62.3 ± 5.4 0.445 0.36 
Stroke volume (mL) 103.8 (82.3 – 132.1) 83.9 (76.2 – 85.9) 0.112 0.37 
Indexed stroke 
volume (mL/kgFFM) 
2.57 ± 0.40 2.57 ± 0.26 0.973 0.00 
LVM/LVEDV 0.63 ± 0.05 0.67 ± 0.06 0.150 0.72 
LVIDd (cm) 5.10 ± 0.38 4.79 ± 0.32 0.060 0.89 
LVIDdi (cm/kgFFM) 0.13 ± 0.02 0.14 ± 0.02 0.064 0.50 
LVIDs (cm) 3.44 ± 0.36 3.06 ± 0.39 0.037 1.01 
LVIDsi (cm/kgFFM) 0.09 ± 0.01 0.09 ± 0.01 0.330 0.00 
IVST (cm) 0.99 ± 0.11 0.90 ± 0.10 0.066 0.86 
IVSTi (cm/kgFFM) 0.02 ± 0.004 0.03 ± 0.003 0.196 0.57 
 
LVM, left ventricular mass; LVMi, left ventricular mass index; LVEDV, left ventricular end-
diastolic volume; LVEDVi, left ventricular end-diastolic volume index; LVESV, left 
ventricular end-systolic volume; LVESVi, left ventricular end-systolic volume index; LVIDd, 
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left ventricular internal diameter during diastole; LVIDdi, left ventricular internal diameter 
during diastole index; LVIDs, left ventricular internal diameter during systole; LVIDsi, left 
ventricular internal diameter during systole index; IVST, interventricular septal thickness; 
IVSTi, interventricular septal thickness index   
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Table 3. Differences in systolic and diastolic echocardiographic function between obese and 
normal-weight adolescents 
 
Obese (n = 9) Normal-weight (n = 11) P value ES 
GLS (%) -15.50 ± 2.72 -21.79 ± 3.60 <0.001 1.94 
SRS (s
-1
) -0.87 ± 0.15 -1.04 ± 0.18 0.037 1.02 
SRE (s
-1
) 1.76 ± 0.30 2.37 ± 0.36 0.001 0.82 
SRA (s
-1
) 0.52 ± 0.18 0.61 ± 0.17 0.254 0.52 
S' (cm/s) 8.9 ± 1.0 11.6 ± 2.2 0.003 1.53 
e' (cm/s) 15.8 ± 2.7 18.1 ± 2.1 0.045 0.96 
A' (cm/s) 6.3 ± 0.9 7.4 ± 1.2 0.041 1.02 
E (cm/s) 83.1 ± 13.6 93.4 ± 13.6 0.112 0.78 
E/e' 5.23 ± 1.00 5.33 ± 0.86 0.825 0.11 
E/A 2.39 ± 0.68 2.06 ± 0.62 0.259 0.51 
A (cm/s) 35.2 ± 9.4 48.3 ± 13.0 0.022 1.14 
 
GLS, global longitudinal strain; SRs, systolic strain rate; SRE, early diastolic strain rate; SRA, 
late diastolic strain rate; S’, peak systolic tissue velocity; e’, peak early diastolic tissue 
velocity; A’, peak late diastolic tissue velocity; E, peak early diastolic mitral flow; A, peak 
late diastolic mitral flow   
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Table 4. Univariate linear regression showing LV function and morphology associations with 
adiposity, insulin resistance and cardiorespiratory fitness in all adolescents (n = 20). 
Unstandardised beta (β) regression coefficients, SE (standard error of β) and 95 % CI of β are 
presented.  
 r value β SE 95 % CI P value 
GLS (%)      
Total body fat (%) 0.54 0.172 0.064 0.038– 0.307 0.015 
VAT volume (cm
3
) 0.67 0.010 0.003 0.004 – 0.016 0.001 
SAT volume (cm
3
) 0.71 0.001 0.000 0.001 – 0.002 < 0.001 
TAAT volume (cm
3
) 0.71 0.001 0.000 0.001 – 0.002 < 0.001 
EATi (cm
3
/kgFFM) 0.30 4.660 0.345 -2.588 – 11.908 0.193 
HOMA-IR 0.63 4.572 1.393 1.619 – 7.524 0.005 
Basal DI 0.58 -0.197 0.069 -0.343 – -0.051 0.011 
VO2peak (mL/kg/min) 0.50 -0.169 0.070 -0.315 – -0.023 0.026 
VO2peak 
(mL/kg
FFM
/min) 
0.39 -0.175 0.098 -0.381 – 0.030 0.090 
Systolic BP (mmHg) 0.68 0.364 0.093 0.168 – 0.559 0.001 
Diastolic BP (mmHg) 0.60 0.446 0.141 0.151 – 0.741 0.005 
SRS (s
-1
)      
Total body fat (%) 0.28 0.004 0.003 -0.003 – 0.010 0.228 
VAT volume (cm
3
) 0.36 0.000 0.000 0.000 – 0.001 0.123 
SAT volume (cm
3
) 0.50 0.000 0.000 0.000 – 0.000 0.026 
TAAT volume (cm
3
) 0.49 0.000 0.000 0.000 – 0.000 0.030 
EATi (cm
3
/kgFFM) 0.21 0.130 0.145 -0.175 – 0.436 0.381 
HOMA-IR 0.26 0.075 0.071 -0.076 – 0.227 0.307 
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Basal DI 0.31 -0.004 0.003 -0.011 – 0.003 0.211 
VO2peak (mL/kg/min) 0.30 -0.004 0.003 -0.011 – 0.002 0.202 
VO2peak 
(mL/kg
FFM
/min) 
0.29 -0.005 0.004 -0.014 – 0.003 0.210 
Systolic BP (mmHg) 0.66 0.014 0.004 0.006 – 0.023 0.002 
Diastolic BP (mmHg) 0.67 0.020 0.005 0.009 – 0.032 0.001 
SRE (s
-1
)      
Total body fat (%) 0.64 -0.020 0.006 -0.033 – -0.008 0.002 
VAT volume (cm
3
) 0.64 -0.001 0.000 -0.002 – 0.000 0.002 
SAT volume (cm
3
) 0.72 0.000 0.000 0.000 – 0.000 <0.001 
TAAT volume (cm
3
) 0.72 0.000 0.000 0.000 – 0.000 <0.001 
EATi (cm
3
/kgFFM) 0.32 -0.491 0.341 -1.208 – 0.226 0.167 
HOMA-IR 0.53 -0.376 0.153 -0.700 – -0.053 0.025 
Basal DI 0.26 0.009 0.008 -0.009 – 0.026 0.305 
VO2peak (mL/kg/min) 0.58 0.020 0.007 0.006 – 0.033 0.008 
VO2peak 
(mL/kg
FFM
/min) 
0.43 0.019 0.010 -0.001 – 0.039 0.059 
Systolic BP (mmHg) 0.37 -0.020 0.012 -0.044 – 0.005 0.107 
Diastolic BP (mmHg) 0.41 -0.030 0.016 -0.064 – 0.003 0.075 
SRA (s
-1
)      
Total body fat (%) 0.29 -0.004 0.003 -0.010 – 0.002 0.214 
VAT volume (cm
3
) 0.12 0.000 0.000 0.000 – 0.000 0.602 
SAT volume (cm
3
) 0.32 0.000 0.000 0.000 – 0.000 0.174 
TAAT volume (cm
3
) 0.30 0.000 0.000 0.000 – 0.000 0.201 
EATi (cm
3
/kgFFM) 0.19 -0.112 0.139 -0.403 – 0.179 0.430 
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HOMA-IR 0.21 0.059 0.069 -0.086 – 0.205 0.399 
Basal DI 0.45 -0.006 0.003 -0.012 – 0.000 0.064 
VO2peak (mL/kg/min) 0.59 0.003 0.003 -0.003 – 0.010 0.279 
VO2peak 
(mL/kg
FFM
/min) 
0.17 0.003 0.004 -0.006 – 0.012 0.480 
Systolic BP (mmHg) 0.18 -0.004 0.005 -0.014 – 0.006 0.436 
Diastolic BP (mmHg) 0.33 -0.010 0.006 -0.023 – 0.004 0.157 
LVMi (g/kgFFM)      
Total body fat (%) 0.19 -0.004 0.005 -0.014 – 0.006 0.436 
VAT volume (cm
3
) 0.01 0.000 0.000 0.000 – 0.000 0.960 
SAT volume (cm
3
) 0.19 0.000 0.000 0.000 – 0.000 0.431 
TAAT volume (cm
3
) 0.17 0.000 0.000 0.000 – 0.000 0.482 
EATi (cm
3
/kgFFM) 0.04 0.037 0.233 -0.453 – 0.527 0.874 
HOMA-IR 0.07 0.032 0.116 -0.214 – 0.277 0.789 
Basal DI 0.06 0.001 0.005 -0.010 – 0.013 0.805 
VO2peak (mL/kg/min) 0.18 0.004 0.005 -0.007 – 0.015 0.450 
VO2peak 
(mL/kg
FFM
/min) 
0.10 0.003 0.007 -0.011 – 0.017 0.674 
Systolic BP (mmHg) 0.12 0.004 0.008 -0.013 – 0.021 0.604 
Diastolic BP (mmHg) 0.13 -0.006 0.011 -0.030 – 0.018 0.598 
 
GLS, global longitudinal strain; SRs, systolic strain rate; SRE, early diastolic strain rate; SRA, 
late diastolic strain rate; LVMi, left ventricular mass index; BP, blood pressure; VAT, 
visceral adipose tissue; SAT, subcutaneous adipose tissue; TAAT, total abdominal adipose 
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tissue; EATi, epicardial adipose tissue index; VO2peak, peak oxygen uptake; HOMA-IR, 
HOMA of insulin resistance; DI, disposition index 
